Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Sales/Fixed Asset

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Sales/Fixed Asset(x) 1.240.890.760.861.07

What is the latest Sales/Fixed Asset ratio of NATCO PHARMA ?

The latest Sales/Fixed Asset ratio of NATCO PHARMA is 1.24 based on Mar2024 Consolidated results.
Year Sales/Fixed Asset
Mar20241.24
Mar20230.89
Mar20220.76
Mar20210.86
Mar20201.07

How is Sales/Fixed Asset of NATCO PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2024 1.24
39.33
Mar2023 0.89
17.11
Mar2022 0.76
-11.63
Mar2021 0.86
-19.63
Mar2020 1.07 -

Other Financial Ratios of NATCO PHARMA


Compare Sales/Fixed Asset ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,808.9 Cr 10.7% 5.9% -15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

5.9%

-15.1%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses